Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity.
Olavarria
E
E
Prieto
E
E
Roman
A
A
D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000503:physiopathology; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003561:Cytarabine